Hepcidin is a liver-derived peptide hormone and the master regulator of systemic iron homeostasis. Decreased hepcidin expression is a common feature in alcoholic liver disease (ALD) and in mouse models of ethanol loading. Dysregulation of hepcidin signaling in ALD leads to liver iron deposition, which is a major contributing factor to liver injury. The mechanism by which hepcidin is regulated following ethanol treatment is unclear. An increase in liver hypoxia was observed in an acute ethanol-induced liver injury model. The hypoxic response is controlled by a family of hypoxia-inducible transcription factors (HIFs), which are composed of an oxygen-regulated alpha subunit (HIF␣) and a constitutively present beta subunit, aryl hydrocarbon receptor nuclear translocator (HIF/Arnt). Disruption of liver HIF function reversed the repression of hepcidin following ethanol loading. Mouse models of liver HIF overexpression demonstrated that both HIF-1␣ and HIF-2␣ contribute to hepcidin repression in vivo. Ethanol treatment led to a decrease in CCAAT-enhancer-binding protein alpha (C/EBP␣) protein expression in a HIF-dependent manner. Importantly, adenoviral rescue of C/EBP␣ in vivo ablated the hepcidin repression in response to ethanol treatment or HIF overexpression. These data provide novel insight into the regulation of hepcidin by hypoxia and indicate that targeting HIFs in the liver could be therapeutic in ALD. P atients with alcoholic liver disease (ALD) accumulate iron in the liver (23). Free iron enhances reactive oxygen species (ROS) production in the liver, leading to oxidative stress, which is a major contributing factor to alcohol-induced liver injury (53). The development of liver fibrosis positively correlates with liver iron staining in ALD, and the presence of iron deposits in the liver of patients with alcoholic cirrhosis is predictive of death (10). There is compelling evidence that iron-mediated oxidative stress may be an important pathological mechanism for the increased incidence of hepatocellular carcinoma in individuals with hepatic iron overload who consume alcohol (2). Lastly, hepatic iron overload increases the risk of insulin resistance and diabetes due to hepatic inflammation (25).Hepcidin is a small antimicrobial peptide produced in the liver and secreted into the bloodstream which regulates systemic iron homeostasis (24,33). Hepcidin functions by binding to the only known mammalian iron exporter, ferroportin (FPN), which leads to its internalization and degradation (28). FPN is primarily expressed on macrophages of the reticuloendothelial system and absorptive enterocytes in the small intestine (6). Thus, hepcidin acts to restrict intestinal iron absorption and prevent release of iron from stores. Conversely, hepcidin deficiency leads to increased iron absorption and mobilization of iron stores, which can cause iron overload (6, 29). Previous publications have shown that in rodents and humans, hepcidin is downregulated in response to ethanol treatment (5,11,14,16,17,19,20,31). Moreover, it ha...